Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles in injectable vials of Phenylephrine Hydrochloride prompted a recall by ...
It was manufactured by a well-known pharmaceutical company and may be used to treat a specific group of patients managing ...
Hosted on MSN14d
FDA recalls blood pressure drug after potentially fatal contamination | Morning in AmericaA Pennsylvania-based pharmaceutical firm and the FDA issued a recall of an injectable blood pressure medicine after a customer noticed "a visible black particulate matter" in a vial. Dr. Bernard Ashby ...
The recall affects one lot of phenylephrine hydrochloride injection, 10mg/ml, sold to wholesalers, distributors, compounding companies and hospitals. The drug is used to treat low blood pressure ...
The FDA says administering a drug containing particulate matter may cause local irritation or swelling. If the particulates enter blood vessels, it can travel to various organs and potentially ...
Provepharm is recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL at the hospital/institution ...
It's not the only blood pressure medication recall to happen in recent months, but the FDA's concern appears to follow a common theme.
Provepharm said it pulled lot No. 24020027 with December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/mL after getting “a customer complaint from a pharmacy after observing a visible ...
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
As the company’s FDA-posted recall notice explains ... or even death,” the statement said. This drug is used to deal with the lowering of blood pressure under anesthesia.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback